NAT1 and gastric carcinoma: One meta-analysis [24] found NAT1 polymorphism to be related to the risk of lung, colorectal, head and neck, bladder, and gastric carcinomas, but not with prostate, breast, and pancreatic carcinomas and non-Hodgkin’s lymphoma.